Zweig-DiMenna Associates’s Exact Sciences EXAS Stock Holding History

Zweig-DiMenna Associates’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-103,940	Closed	-$7.27M	–	104
2022 Q1	$7.27M	Buy	+103,940	New	+$7.6M	0.97%	42
2021 Q4	–	Sell	-56,113	Closed	-$5.36M	–	129
2021 Q3	$5.36M	Buy	56,113 +1,000	+2%	+$106K	0.37%	93
2021 Q2	$6.85M	Buy	+55,113	New	+$6.58M	0.41%	89
2019 Q4	–	Sell	-42,500	Closed	-$3.84M	–	103
2019 Q3	$3.84M	Buy	+42,500	New	+$4.84M	0.34%	74
2019 Q1	–	Sell	-79,210	Closed	-$5M	–	114
2018 Q4	$5M	Hold	79,210	–	–	0.49%	66
2018 Q3	$6.25M	Sell	79,210 -98,330	-55%	-$6.41M	0.52%	71
2018 Q2	$10.6M	Sell	177,540 -464,118	-72%	-$25M	0.65%	56
2018 Q1	$25.9M	Buy	641,658 +336,883	+111%	+$16.4M	2.29%	10
2017 Q4	$16M	Sell	304,775 -126,066	-29%	-$6.73M	1.74%	15
2017 Q3	$20.3M	Sell	430,841 -3,516	-0.8%	-$142K	1.82%	16
2017 Q2	$15.4M	Buy	+434,357	New	+$13.4M	1.12%	29
2015 Q1	–	Sell	-204,640	Closed	-$5.62M	–	300
2014 Q4	$5.62M	Sell	204,640 -408,110	-67%	-$9.93M	0.24%	109
2014 Q3	$11.9M	Sell	612,750 -136,486	-18%	-$2.5M	0.52%	67
2014 Q2	$12.8M	Buy	+749,236	New	+$10.3M	0.58%	67

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Zweig-DiMenna Associates's EXAS Position: Q2 2022 in Review

Zweig-DiMenna Associates sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 103,940 shares — an estimated $7.27M sold.

Zweig-DiMenna Associates first reported a position in EXAS in Q2 2014 and held it in 14 quarters. The position peaked at $25.9M in Q1 2018. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

Zweig-DiMenna Associates reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
Zweig-DiMenna Associates sold 103,940 Exact Sciences shares in Q2 2022, an estimated $7.27M.
Zweig-DiMenna Associates first reported a position in Exact Sciences in Q2 2014 and held it in 14 quarters.
Zweig-DiMenna Associates's Exact Sciences position peaked at $25.9M in Q1 2018.
501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Zweig-DiMenna Associates's 13F filing for Q2 2022, filed 28 Jul 2022.